期刊文献+

萘普西诺及其对映异构体的HPLC法测定 被引量:1

Determination of Naproxcinod and Its Enantiomer by HPLC
原文传递
导出
摘要 建立了高效液相色谱法测定萘普西诺及其对映异构体。采用Chiralpak AD—H色谱柱,以正己烷:异丙醇(95:5)为流动相,检测波长232nm。萘普西诺在0.015~20μg/ml范围内线性关系良好。萘普西诺与其R-异构体分离良好,回收率为99.4%和96.2%,RSD为0.61%和8.1%。 An HPLC method was established for the determination of naproxcinod and its enantiomer. A Chiralpak AD-H column was used with the mobile phase ofhexane : isopropanol (95 : 5) at the detection wavelength of 232 nm. It was linear for naproxcinod in the range of 0.015 - 20 μg/ml. Naproxcinod was separated with its R-enantiomer efficiently. Their average recoveries were 99.4 % and 96.2 %, with RSDs of 0.61% and 8.1%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2015年第1期52-54,共3页 Chinese Journal of Pharmaceuticals
基金 河北省科技支撑计划项目(13272614和12272604) 河北省自然科学基金资助项目(H2012206125) 河北省教育厅青年基金项目(Q2012028)
关键词 萘普西诺 手性固定相 手性分离 对映体 naproxcinod chiral stationary phase chiral separation enantiomer
  • 相关文献

参考文献7

二级参考文献18

  • 1Wallace JL, Viappiani S, Bolla M. Cyclooxygenaseinhibiting nitric oxide donators for osteoarthritis [J]. Trends Pharmacol Sci, 2009, 30 (3) : 112-117.
  • 2Benedini F, Oldani E, Castaldi G, et al. Process for the preparation of naproxen nitroxyalkylesters: US, 6700011 [P]. 2004-03-02.
  • 3Del Soldato E Nitric esters having anti-inflammatory and/or analgesic activity and process for their perparation: WO, 9509831 [P]. 1995-04-13.
  • 4Belli A, Cannata V, Fonduca T, et al. New process: WO, 03045896 [P]. 2003-06-05.
  • 5于兆文,高等学校化学学报,1999年,20卷,1376页
  • 6樊能廷.有机合成事典[M].北京:北京理工大学出版社,1995.666.
  • 7Jorgen AC,Richard FS. US Patent,4007196. 1981
  • 8Curzons AD, Richardson JE, Wood - Kaczmar MW. US Patent,2003187269. 2003
  • 9Borrett GT, Fedouloff M, Hughes M J, et al. WO Patent,2002006275,2002
  • 10Neal W. WO Patent,2001002357,2001

共引文献11

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部